Imperial College London
Alternate

Professor Molly Stevens

Faculty of Engineering, Department of Materials

Professor of Biomedical Materials and Regenerative Medicine
 
 
 
//

Contact

 

+44 (0)20 7594 6804m.stevens

 
 
//

Location

 

208Royal School of MinesSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Fuhrmann:2018:10.1002/adma.201706616,
author = {Fuhrmann, G and Chandrawati, R and Parmar, P and Keane, TJ and Maynard, SA and Bertazzo, S and Stevens, MM},
doi = {10.1002/adma.201706616},
journal = {Advanced Materials},
title = {Engineering extracellular vesicles with the tools of enzyme prodrug therapy},
url = {http://dx.doi.org/10.1002/adma.201706616},
volume = {30},
year = {2018}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Extracellular  vesicles (EVs)  have  been  exploited  as  drug  delivery  vehicles but  their therapeutic use may be limited due to off-target  effects. To harness EVs’inherent properties and  to  couple  them  with  site-specific  drug  delivery  functions,  EVs  are  incorporated  into hydrogels and engineered with the tools of enzyme-prodrug therapy. Local sustained release of anti-inflammatory drugs is demonstrated in macrophage cell models.
AU  - Fuhrmann,G
AU  - Chandrawati,R
AU  - Parmar,P
AU  - Keane,TJ
AU  - Maynard,SA
AU  - Bertazzo,S
AU  - Stevens,MM
DO  - 10.1002/adma.201706616
PY  - 2018///
SN  - 0935-9648
TI  - Engineering extracellular vesicles with the tools of enzyme prodrug therapy
T2  - Advanced Materials
UR  - http://dx.doi.org/10.1002/adma.201706616
UR  - http://hdl.handle.net/10044/1/55529
VL  - 30
ER  -
Download